RPRX β€” ROYALTY PHARMA

Ownership history in Goodman Advisory Group, LLC  Β·  2 quarters on record

This page tracks every 13F SEC filing in which Goodman Advisory Group, LLC reported a position in ROYALTY PHARMA (RPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
2.67% (2025 Q4)
πŸ“Š Avg. % of fund
2.65%
πŸ“… First filed
2025 Q3
πŸ“… Last filed
2025 Q4
⏱ Quarters held
2
% of Fund (quarterly)    RPRX price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 2 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 281,194 -18,113 -6.1% 2.67% $10.9M $38.44
2025 Q3 INITIATED 299,307 β€” β€” 2.63% $10.6M $34.90

🏒 Other funds also holding RPRX

As of 2025 Q4 β€” sorted by position size

Dorsey Asset Management, LLC 3Y 7Y 7.59% Regal Partners Ltd 3Y 7Y 5.88% Caledonia (Private) Investments Pty Ltd 3Y 7Y 5.46% NEW SOUTH CAPITAL MANAGEMENT INC 3Y 7Y 5.21% Patient Capital Management, LLC 3Y 4.97% Lion Point Capital, LP 3Y 7Y 4.28% TORRAY INVESTMENT PARTNERS LLC 3Y 7Y 4.12% CM Management, LLC 3Y 2.44% Inlet Private Wealth, LLC 3Y 7Y 2.02% HOMESTEAD ADVISERS CORP 3Y 7Y 1.71%
← Back to Goodman Advisory Group, LLC Holdings